FDA-CDER-CDRH, SNMMI, and MITA Workshop | Quantitative Brain Amyloid PET Imaging in Patients with Alzheimer’s Disease - 11/17/2022

[FDA]

This workshop is intended for a diverse group of scientists, responsible for the evaluation of quantitative positron emission tomography (PET) measures of amyloid deposition in the brain in clinical trials and clinical use in patients with suspected or confirmed Alzheimer's disease.


Baca selengkapnya di : http://www.fda.gov...